Answers are grounded in this paper and cite their sources.
Analysis evaluates costs of genomic testing in oncology, suggesting increased use of NGS for patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Grossman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: